Mibefradil improves skeletal muscle mass, function and structure in obese mice.
10.12122/j.issn.1673-4254.2022.07.10
- Author:
Jiang Hao WU
1
;
Yong Xin WU
1
;
Yun Fei YANG
1
;
Jing YU
1
;
Rao FU
1
;
Yue SUN
1
;
Qian XIAO
1
Author Information
1. Department of Geriatrics, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Publication Type:Randomized Controlled Trial, Veterinary
- Keywords:
T-type calcium channel;
autophagy;
mibefradil;
obesity;
skeletal muscles
- MeSH:
Animals;
Body Weight;
Diet, High-Fat;
Mibefradil/metabolism*;
Mice;
Mice, Inbred C57BL;
Mice, Obese;
Muscle, Skeletal/metabolism*;
Proto-Oncogene Proteins c-akt/metabolism*;
TOR Serine-Threonine Kinases/metabolism*
- From:
Journal of Southern Medical University
2022;42(7):1032-1037
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effect of mibefradil on skeletal muscle mass, function and structure in obese mice.
METHODS:Fifteen 6-week-old C57BL/6 mice were randomized equally into normal diet group (control group), high-fat diet (HFD) group and high-fat diet +mibefradil intervention group (HFD +Mibe group). The grip strength of the mice was measured using an electronic grip strength meter, and the muscle content of the hindlimb was analyzed by X-ray absorptiometry (DXA). Triglyceride (TG) and total cholesterol (TC) levels of the mice were measured with GPO-PAP method. The cross-sectional area of the muscle fibers was observed with HE staining. The changes in the level of autophagy in the muscles were detected by Western blotting and immunofluorescence assay, and the activation of the Akt/mTOR signaling pathway was detected with Western blotting.
RESULTS:Compared with those in the control group, the mice in HFD group had a significantly greater body weight, lower relative grip strength, smaller average cross sectional area of the muscle fibers, and a lower hindlimb muscle ratio (P < 0.05). Immunofluorescence assay revealed a homogenous distribution of LC3 emitting light red fluorescence in the cytoplasm in the muscle cells in HFD group and HFD+Mibe group, while bright spots of red fluorescence were detected in HFD group. In HFD group, the muscular tissues of the mice showed an increased expression level of LC3 II protein with lowered expressions of p62 protein and phosphorylated AKT and mTOR (P < 0.05). Mibefradil treatment significantly reduced body weight of the mice, lowered the expression level of p62 protein, and increased forelimb grip strength, hindlimb muscle ratio, cross-sectional area of the muscle fibers, and the expression levels of LC3 II protein and phosphorylated AKT and mTOR (P < 0.05).
CONCLUSION:Mibefradil treatment can moderate high-fat diet-induced weight gain and improve muscle mass and function in obese mice possibly by activating AKT/mTOR signal pathway to improve lipid metabolism and inhibit obesityinduced autophagy.
